亚塞纳根资产管理公司在第二季度大幅增加了对阿伯维公司的股份. Assenagon Asset Management significantly increased its stake in AbbVie Inc. in Q2.
亚塞纳根资产管理公司在第二季度增加了对阿伯维公司 (纽约证券交易所:ABBV) 的股份314.1%,现在拥有1,315,000股. Assenagon Asset Management S.A. increased its stake in AbbVie Inc. (NYSE: ABBV) by 314.1% in Q2, now owning 1,315,000 shares. 机构投资者持有公司70.23%的股票,AbbVie在第二季度报告了2.65美元的每股收益,超过了共识估计. Institutional investors hold 70.23% of the company's stock, with AbbVie reporting $2.65 EPS for Q2, beating the consensus estimate. Barclays、Morgan Stanley和Wells Fargo & Company等几家公司的分析师对ABBV股份进行了“超重”评级。 Analysts from several firms including Barclays, Morgan Stanley, and Wells Fargo & Company have issued "overweight" ratings on ABBV shares. AbbVie的市场上限为3 424.0亿美元,P/E比率为57.28,Beta为0.64。 AbbVie has a market cap of $342.40 billion, a P/E ratio of 57.28, and a beta of 0.64.